FDA Launches Protocol For Inspections Of Sterile Drug Manufacturing Facilities

 
• By Bowman Cox

US FDA expects the New Inspection Protocol Project (NIPP) it launched Nov. 9 to increase the consistency of its sterile manufacturing inspections – and the ability of those inspections to catch quality problems before they could lead to drug shortages.

Investigators in Clean Room
FDA INVESTIGATORS INSPECT A PHARMACY CLEANROOM • Source: US Justice Department

More from Manufacturing

More from Compliance